Does UnitedHealthcare Cover Rehab?

Evaluating addiction-treatment coverage under UnitedHealthcare requires distinguishing three elements: statutory obligation (comprehensive under MHPAEA), benefit design (deductible $500–$8,500, coinsurance 15–30% coinsurance, out-of-pocket maximum $6,000–$18,000 per family), and operational conduct (authorization requirements, network adequacy, appeals administration). Each is treated separately in this document.

Parity enforcement — what the 2024 rule changed

UnitedHealthcare's parity compliance framework is governed federally through Department of Labor enforcement (for ERISA plans) and through state insurance commissioner oversight (for individual and small-group markets). On the empirical side, UnitedHealthcare has been among the insurers more responsive to documented medical-necessity cases post-2024, though variation by plan product remains meaningful. The 2024 rule's operational consequences for UnitedHealthcare include: (a) mandatory disclosure of medical-necessity criteria; (b) documented comparability analysis for NQTLs; (c) accelerated external-review pathways for denied behavioral-health claims.

UnitedHealthcare plan types

The UnitedHealthcare product portfolio — Choice Plus PPO, Navigate HMO, Charter Open Access, Medicare Advantage, TRICARE Prime Remote (select regions) — reflects differentiated benefit design by market segment (employer group, individual, Medicare, Medicaid-managed, military administration). Network adequacy assessments and medical-necessity criteria can vary meaningfully across these products. The Summary of Benefits and Coverage (SBC) document for the specific product should be the baseline reference for benefit verification.

A note on medication-assisted treatment

Federal guidance — SAMHSA TIP 63, NIDA Research Reports, ASAM Criteria 4e — designates MAT with buprenorphine, methadone, or naltrexone as first-line treatment for opioid use disorder. UnitedHealthcare's current MAT coverage: buprenorphine, methadone, naltrexone all covered; Sublocade and Vivitrol sometimes require PA. Departures from consensus MAT standards in a plan's medical-necessity criteria are actionable under the 2024 parity rule's clinical-alignment requirement.

When UnitedHealthcare denies — appeal playbook

Appeal strategy for UnitedHealthcare denials should focus on three documents: (1) the specific medical-necessity criteria applied in the denial (disclosable under 2024 parity rule on request within 10 business days); (2) the comparative analysis UnitedHealthcare produced demonstrating parity compliance for the non-quantitative treatment limit in question; (3) an ASAM 4e-aligned clinical assessment from an independent treating clinician. Appeals that cite specific criteria against specific clinical documentation have substantially higher reversal rates than appeals that argue clinical judgment in general terms.

Before admission

The operational prerequisites for a UnitedHealthcare admission are: (a) confirmed in-network status for the specific product (HMO/PPO/etc.); (b) documented prior authorization with specific day-count authorized; (c) written Verification of Benefits from the facility; (d) current formulary review for any MAT medication. Proceeding on verbal confirmation alone is a common source of cost-sharing disputes at claim adjudication.